With the analysis among 279 patents, we discovered top 52 key players by total patent application. Quratis, Inc., Laboratoire Francais du Fractionnement et des Biotechnologies S.A., Biogen MA, Inc. are dominant in this area. They take 24.01% of the total patent filing.
Massachusetts, United States
Patent: 20
New South Wales, Australia
Patent: 15
Tokyo-to, Japan
Patent: 14
New Jersey, United States
Patent: 13
Tokyo-to, Japan
Patent: 11
Tokyo-to, Japan
Patent: 10
With the analysis among 55 patents, we discovered top 6 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, PDC Line Pharma SASU, Asgard Therapeutics AB are active in this area.
Massachusetts, United States
Patent: 2
Massachusetts, United States
Patent: 1
With the analysis among related 134 patents applied in the last 5 years. We discover 54 most active companies in this area. The fast-growing Quratis, Inc., Tufts Medical Center, Inc., Établissement Français du Sang take 31.34% of patent filing during this period.
Massachusetts, United States
Patent: 9
Chiba-ken, Japan
Patent: 6
Midtjylland, Denmark
Patent: 6
Chiba-ken, Japan
Patent: 6
With the analysis among related 134 patents in last 5 years, we discover 37 new entrants. Tufts Medical Center, Inc., PDC Line Pharma SASU, Kikkoman Corp. are the most active new entrants in this area.
Massachusetts, United States
Patent: 9
Chiba-ken, Japan
Patent: 6
Midtjylland, Denmark
Patent: 6
Chiba-ken, Japan
Patent: 6
undefined undefined
Patent: 5
New Jersey, United States
Patent: 5
With the analysis among 124 patents, we discovered top 19 universities and scientific research institutions by total patent application. Université d'Aix-Marseille, Université Claude Bernard Lyon 1, University of Zurich are dominant in this area. They take 73.39% of the total patent filing.
ZURICH, Switzerland
Patent: 11
North Carolina, United States
Patent: 10
Sachsen, Germany
Patent: 7
Chiba-ken, Japan
Patent: 6
Oost-Vlaanderen, Belgium
Patent: 3
California, United States
Patent: 2